Creo Medical Limited
CREO.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £70,525 | £143,982 | £47,443 | £253,868 |
| - Cash | £8,700 | £3,000 | £13,097 | £43,534 |
| + Debt | £4,400 | £8,300 | £11,700 | £10,556 |
| Enterprise Value | £66,225 | £149,282 | £46,046 | £220,890 |
| Revenue | £4,000 | £30,800 | £27,169 | £25,161 |
| % Growth | -87% | 13.4% | 8% | – |
| Gross Profit | £1,900 | £15,300 | £10,009 | £9,023 |
| % Margin | 47.5% | 49.7% | 36.8% | 35.9% |
| EBITDA | -£26,100 | -£20,700 | -£27,616 | -£27,540 |
| % Margin | -652.5% | -67.2% | -101.6% | -109.5% |
| Net Income | -£28,700 | -£21,700 | -£26,936 | -£24,595 |
| % Margin | -717.5% | -70.5% | -99.1% | -97.8% |
| EPS Diluted | -0.079 | -0.069 | -0.14 | -0.14 |
| % Growth | -14.6% | 50.5% | 0% | – |
| Operating Cash Flow | -£22,200 | -£21,600 | -£24,988 | -£25,980 |
| Capital Expenditures | -£400 | -£1,200 | -£3,274 | -£6,122 |
| Free Cash Flow | -£22,600 | -£22,800 | -£28,262 | -£32,102 |